Role of regulatory and suppressor T-cells in the induction of ILT3 + ILT4+ tolerogenic endothelial cells in organ allografts

Transplant Immunology

Volumn 13, Issue 2, 2004, Pages 73-82

  Cortesini, Nicole Suciu Foca ^a   Colovai, Adriana I ^a   Manavalan, John S ^a   Galluzzo, Sara ^a   Naiyer, Afzal J ^a   Liu, Jiawang ^a   Vlad, George ^a   Kim Schulze, Seunghee ^a   Scotto, Luigi ^a   Fan, Jianshe ^a   Cortesini, Raffaello ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Direct allorecognition; Endothelial cells; Indirect recognition; T regulatory cells; T suppressor cells

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 3; IMMUNOGLOBULIN LIKE TRANSCRIPT 4; PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLOGRAFT; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CELL ACTIVITY; CELL FUNCTION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HELPER CELL; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 4544227160     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.06.001     Document Type: Article

References (95)

1. Rothstein D.M., Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196:2003;85
2. Zheng X.X., Sanchez-Fueyo A., Domenig C., Strom T.B. The balance of deletion and regulation in allograft tolerance. Immunol. Rev. 196:2003;75
3. Suchin E.J., Langmuir P.B., Palmer E., Sayegh M.H., Wells A.D., Turka L.A. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166(2):2001;973
4. Waldmann H., Cobbold S. Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity. 14(4):2001;399
5. Cobbold S.P., Nolan K.F., Graca L., Castejon R., LeMoine A., Frewin M., et al. Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms. Immunol. Rev. 196:2003;109
6. Kirk A.D. Crossing the bridge: large animal models in translational transplantation research. Immunol. Rev. 196:2003;176
7. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev., Immunol. 3(3):2003;199
8. Shevach E.M. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 193(11):2001;F41
9. Taylor P.A., Noelle R.J., Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193(11):2001;1311
10. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196(3):2002;389
11. Marrack P., Kappler J. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature (Lond). 322:1986;840
12. Matis L.A., Sorger S.B., McElligott D.L., Fink P.J., Hedrick S.M. The molecular basis of alloreactivity in antigen-specific, major histocompatibility complex-restricted T cell clones. Cell. 51(1):1987;59
13. Bevan M.J. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today. 5:1984;128
14. Lechler R.I., Lombardi G., Batchelor J.R., Reinsmoen N., Bach F.H. The molecular basis of alloreactivity. Immunol. Today. 11(3):1990;83
15. Sprent J., Schaefer M., Lo D., Korngold R. Properties of purified T cell subsets: II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163(4):1986;998
16. Rosenberg A.S., Mizuochi T., Sharrow S.O., Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 163:1987;1296
17. Ichikawa T., Nakayama E., Uenaka A., Monden M., Mori T. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J. Exp. Med. 166(4):1987;982
18. Rosenberg A.S., Munitz T.I., Maniero T.G., Singer A. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo. J. Exp. Med. 173(6):1991;1463
19. Lombardi G., Sidhu S., Batchelor J.R., Lechler R.I. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. U. S. A. 86(11):1989;4190
20. Bradley J.A., Mowat A.M., Bolton E.M. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. Immunol. Today. 13(11):1992;434
21. Fangmann J., Dalchau R., Fabre J.W. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med. 175(6):1992;1521
22. Benichou G., Takizawa P.A., Olson C.A., McMillan M., Sercarz E.E. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175(1):1992;305
23. Liu Z., Braunstein N.S., Suciu-Foca N. T cell recognition of allopeptides in context of syngeneic MHC. J. Immunol. 148(1):1992;35
24. DeKoster H.S., Anderson D.C., Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp. Med. 169:1989;1191
25. Murphy D.B., Lo D., Rath S., Brinster R.L., Flavell R.A., Slanetz A., et al. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature. 338(6218):1989;765
26. Rudensky A., Rath S., Preston-Hurlburt P., Murphy D.B., Janeway C.A. Jr. On the complexity of self. Nature. 353(6345):1991;660
27. Suciu-Foca N., Reed E., D'Agati V.D., Ho E., Cohen D.J., Benvenisty A.I., et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation. 51(3):1991;593
28. Suciu-Foca N., Reed E., Marboe C., Harris P., Yu P.X., Sun Y.K., et al. The role of anti-HLA antibodies in heart transplantation. Transplantation. 51(3):1991;716
29. Harris P.E., Liu Z., Suciu-Foca N. MHC class II binding of peptides derived from HLA-DR 1. J. Immunol. 148(7):1992;2169
30. Liu Z., Sun Y.K., Xi Y.P., Maffei A., Reed E., Harris P., et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177(6):1993;1643
31. Lechler R.I., Batchelor J.R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155(1):1982;31
32. Liu Z., Colovai A.I., Tugulea S., Reed E.F., Fisher P.E., Mancini D., et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J. Clin. Invest. 98(5):1996;1150
33. Vanderlugt C.J., Miller S.D. Epitope spreading. Curr. Opin. Immunol. 8(6):1996;831
34. Mamula M.J., Janeway C.A. Jr. Do B cells drive the diversification of immune responses? Immunol. Today. 14(4):1993;151
35. Reed E.F., Hong B., Ho E., Harris P.E., Weinberger J., Suciu-Foca N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 61(4):1996;566
36. Sayegh M.H., Watschinger B., Carpenter C.B. Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation. 57(9):1994;1295
37. Gallon L., Watschinger B., Murphy B., Akalin E., Sayegh M.H., Carpenter C.B. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation. 59(4):1995;612
38. Sayegh M.H., Carpenter C.B. Role of indirect allorecognition in allograft rejection. Int. Rev. Immunol. 13(3):1996;221
39. Hosenpud J.D., Morris T.E., Shipley G.D., Mauck K.A., Wagner C.R. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation. 61(6):1996;939
40. Wagner C.R., Morris T.E., Shipley G.D., Hosenpud J.D. Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J. Clin. Invest. 92(3):1993;1269
41. Lehmann P.V., Sercarz E.E., Forsthuber T., Dayan C.M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today. 14(5):1993;203
42. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183(4):1996;1777
43. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:1993;729
44. Benichou G., Fedoseyeva E., Lehmann P.V., Olson C.A., Geysen H.M., McMillan M., et al. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J. Immunol. 153(3):1994;938
45. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 314(6011):1985;537
46. Casten L.A., Pierce S.K. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J. Immunol. 140(2):1988;404
47. Yoshikawa M., Watanabe M., Hozumi N. Analysis of proteolytic processing during specific antigen presentation. Cell. Immunol. 110(2):1987;431
48. Vidard L., Rock K.L., Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J. Immunol. 149(6):1992;1905
49. Elson C.J., Barker R.N., Thompson S.J., Williams N.A. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol. Today. 16(2):1995;71
50. Benichou G., Fedoseyeva E.V. The contribution of peptides to T cell allorecognition and allograft rejection. Int. Rev. Immunol. 13(3):1996;231
51. Liu Z., Harris P.E., Colovai A.I., Reed E.F., Maffei A., Suciu-Foca N. Indirect recognition of donor MHC Class II antigens in human transplantation. Clin. Immunol. Immunopathol. 78(3):1996;228
52. Lederman S., Suciu-Foca N. Antigen presenting cells integrate opposing signals from CD4+ and CD8+ regulatory T lymphocytes to arbitrate the outcomes of immune responses. Hum. Immunol. 60(7):1999;533
53. Lanzavecchia A. Immunology. License to kill. Nature. 393(6684):1998;413
54. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180(4):1994;1263
55. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184(2):1996;747
56. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3):1995;1151
57. Ng W.F., Duggan P.J., Ponchel F., Matarese G., Lombardi G., Edwards A.D., et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 98(9):2001;2736
58. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193(11):2001;1285
59. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162(9):1999;5317
60. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3(2):2002;135
61. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16(2):2002;311
62. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299(5609):2003;1057
63. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4(4):2003;337
64. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4(4):2003;330
65. Liu Z., Tugulea S., Cortesini R., Suciu-Foca N. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+ CD28- T cells. Int. Immunol. 10(6):1998;775
66. Ciubotariu R., Colovai A.I., Pennesi G., Liu Z., Smith D., Berlocco P., et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J. Immunol. 161(10):1998;5193
67. Jiang S., Tugulea S., Pennesi G., Liu Z., Mulder A., Lederman S., et al. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum. Immunol. 59(11):1998;690
68. Colovai A.I., Liu Z., Ciubotariu R., Lederman S., Cortesini R., Suciu-Foca N. Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation. 69(7):2000;1304
69. Liu Z., Tugulea S., Cortesini R., Lederman S., Suciu-Foca N. Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum. Immunol. 60(7):1999;568
70. Li J., Liu Z., Jiang S., Cortesini R., Lederman S., Suciu-Foca N. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J. Immunol. 163(12):1999;6386
71. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3(3):2002;237
72. Suciu-Foca Cortesini N., Piazza F., Ho E., Ciubotariu R., LeMaoult J., Dalla-Favera R., et al. Distinct mRNA microarray profiles of tolerogenic dendritic cells. Hum. Immunol. 62(10):2001;1065
73. Colonna M., Nakajima H., Navarro F., Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66(3):1999;375
74. Colonna M., Nakajima H., Cella M. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 12(2):2000;121
75. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160(7):1998;3096
76. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science. 290(5489):2000;84
77. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185(10):1997;1743
78. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11(3-4):2003;245
79. Shortman K., Heath W.R. Immunity or tolerance? That is the question for dendritic cells. Nat. Immunol. 2(11):2001;988
80. Albert M.L., Jegathesan M., Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2(11):2001;1010
81. Cortesini R., LeMaoult J., Ciubotariu R., Cortesini N.S. CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol. Rev. 182:2001;201
82. Kreisel D., Krupnick A.S., Gelman A.E., Engels F.H., Popma S.H., Krasinskas A.M., et al. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 8(3):2002;233
83. Dengler T.J., Pober J.S. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J. Immunol. 164(10):2000;5146
84. Biedermann B.C., Pober J.S. Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J. Immunol. 162(12):1999;7022
85. Pober J.S., Bothwell A.L., Lorber M.I., McNiff J.M., Schechner J.S., Tellides G. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin. Immunopathol. 25(2):2003;167
86. Savage C.O., Brooks C.J., Harcourt G.C., Picard J.K., King W., Sansom D.M., et al. Human vascular endothelial cells process and present autoantigen to human T cell lines. Int. Immunol. 7(3):1995;471
87. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6(12):2000;1348
88. Savinov A.Y., Wong F.S., Stonebraker A.C., Chervonsky A.V. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J. Exp. Med. 197(5):2003;643
89. Marelli-Berg F.M., Scott D., Bartok I., Peek E., Dyson J., Lechler R.I. Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation? J. Immunol. 165(8):2000;4182
90. Valujskikh A., Heeger P.S. Emerging roles of endothelial cells in transplant rejection. Curr. Opin. Immunol. 15(5):2003;493
91. Manavalan JS, im-Schulze S. Scotto L. Naiyer AJ, Vlad G, Colombo PC, et al. Alloantigen specific CD8+CD28-FoxP3+T suppressor cells induce ILT3+ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol. 2004 Jun 28 [Unpublished ahead of print].
92. Colovai A.I., Mirza M., Vlad G., Wang S., Ho E., Cortesini R., et al. Regulatory CD8+CD28- T cells in heart transplant recipients. Hum. Immunol. 64(1):2003;31
93. Ciubotariu R., Vasilescu R., Ho E., Cinti P., Cancedda C., Poli L., et al. Detection of T suppressor cells in patients with organ allografts. Hum. Immunol. 62(1):2001;15
94. Cortesini R., Renna Molajoni E., Cinti P., Pretagostini R., Ho E., Rossi P., et al. Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T suppressor cells. Hum. Immunol. 63(11):2002;1010
95. Suciu Foca N., Manavalan J.S., Cortesini R. Generation and function of antigen specific suppressor and regulatory T cells. Transpl. Immunol. 11(3-4):2003;235